Evidence map›Paper›PMID 42396876›Full record

ReviewCA: a cancer journal for clinicians

Serious mental illness and cancer: A call to action for equitable care.

Daniel McFarland, Cristiane Bergerot, Pernille Bidstrup, Miri Cohen, Paul D'Alton, Shahrzad Zamani, Louise Mullen, Michelle Riba, Luigi Grassi, Kelly Irwin

Erratum issuedAbstract readReview
In one paragraph

Review in CA: a cancer journal for clinicians. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Daniel McFarlandDepartment of Psychiatry, University of Rochester Medical Center, Rochester, New York, USA.ORCID https://orcid.org/0000-0002-5500-1591
Cristiane BergerotOncoclinicas and Co-Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil.ORCID https://orcid.org/0000-0003-0037-0303
Pernille BidstrupDanish Cancer Institute, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-9704-6800
Miri CohenSchool of Social Work, University of Haifa, Haifa, Israel.ORCID https://orcid.org/0000-0003-1220-3852
Paul D'AltonSchool of Psychology, University College Dublin, Dublin, Ireland.ORCID https://orcid.org/0000-0003-1420-6248
Shahrzad ZamaniFlorida State University, Tallahassee, Florida, USA.ORCID https://orcid.org/0000-0001-6730-2407
Louise MullenNational Cancer Control Program, Dublin, Ireland.ORCID https://orcid.org/0000-0003-0079-2469
Michelle RibaDepartment of Psychiatry, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-0232-6069
Luigi GrassiDepartment of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-1050-4494
Kelly IrwinDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-4591-9876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer advances are not distributed equitably among many segments of the population. Specifically, individuals with serious mental illness (SMI) face compounded disparities in cancer detection, treatment, and survival. SMI, characterized by conditions such as schizophrenia, bipolar disorder, and severe major depression, is associated with significant functional impairment and a two-to-three-decade reduction in life expectancy. Patients with SMI encounter unique challenges when navigating cancer care, including fragmented care pathways, less access to cancer therapeutics, limited psychosocial support, stigma, heightened vulnerability to diagnostic overshadowing where symptoms are attributed to their psychiatric rather than a medical or oncologic condition, and underrepresentation in therapeutic clinical trials. This review explores the intersection of SMI and cancer care starting with the conceptual background and its importance related to cancer outcomes and the delivery of ethical care to highlight unmet needs and a multitude of barriers. The paper proposes practical recommendations to improve cancer care for individuals with SMI who develop cancer including adopting the collaborative care model, enhancing psychosocial and psychiatric integration in oncology settings, and addressing biases inherent in clinician training. Interventions targeting individual, interpersonal, health system, and policy levels are essential to comprehensively mitigating disparities and developing durable cancer delivery strategies. Equitable cancer care for patients with SMI is both a moral imperative and a cornerstone of advancing social justice in oncology. Thus, there is a critical need to prioritize the translation of research advances, to close the gap in cancer outcomes and mortality, and to improve patient outcomes and wellbeing.

Indexed as

Healthcare DisparitiesMental DisordersNeoplasmsHealth Services AccessibilityHumansSocial Stigmabehavioral oncologyhealth disparities, psychiatrypsychological oncology

Identifiers

PMID42396876
PMCPMC13329970

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.